A carregar...
Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial
AIMS/INTRODUCTION: Insulin degludec/insulin aspart (IDegAsp) is a soluble combination of insulin degludec (70%) and insulin aspart (30%). The present exploratory trial investigated the safety of switching unit‐to‐unit from twice‐daily basal or pre‐mix insulin to twice‐daily IDegAsp in Japanese patie...
Na minha lista:
| Publicado no: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334300/ https://ncbi.nlm.nih.gov/pubmed/27560769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12569 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|